Zeroing in on a Biomarker Test for Parkinson's Disease
Lundbeck is collaborating with experts at the Danish Technical University on a project that aims to facilitate early diagnosis of Parkinson's disease.
Greening Lundbeck, Greening the Grid
With construction of a new solar park now complete, Lundbeck takes a step closer to net-zero emissions.
Lundbeck announced the start of a phase II clinical study to assess Lu AG09222 for migraine prevention
Lu AF82422 represents a novel approach for potential treatment of multiple system atrophy (MSA), which currently represents a high and urgent unmet medical need.